Investor Relations
Welcome to the Allergy Therapeutics Investor Relations Centre.
Here we provide current and potential investors with access to historical and up-to-date information, including share price and trades, press releases, announcements and annual reports, along with other financial related materials and tools.
Allergy Therapeutics was listed on the Alternative Investment Market in October 2004 at an issue price of 73 pence per share.
